These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 21285125

  • 1. Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial.
    Webb NJ, Lam C, Shahinfar S, Strehlau J, Wells TG, Gleim GW, Le Bailly De Tilleghem C.
    Nephrol Dial Transplant; 2011 Aug; 26(8):2521-6. PubMed ID: 21285125
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind, controlled study of losartan in children with proteinuria.
    Webb NJ, Lam C, Loeys T, Shahinfar S, Strehlau J, Wells TG, Santoro E, Manas D, Gleim GW.
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):417-24. PubMed ID: 20089489
    [Abstract] [Full Text] [Related]

  • 3. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [Abstract] [Full Text] [Related]

  • 4. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 5. Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial.
    Kloner RA, Neutel J, Roth EM, Weiss R, Weinberger MH, Thakker KM, Schwartz B, Shi H, Gregg AM, ADHT Investigators.
    Ann Pharmacother; 2008 Nov; 42(11):1552-62. PubMed ID: 18827176
    [Abstract] [Full Text] [Related]

  • 6. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D, Vats A, Moritz ML, Reitz S, Grosso MJ, Janosky JE.
    J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
    [Abstract] [Full Text] [Related]

  • 7. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.
    Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876
    [Abstract] [Full Text] [Related]

  • 8. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
    Wilson TW, Lacourcière Y, Barnes CC.
    CMAJ; 1998 Sep 08; 159(5):469-76. PubMed ID: 9757170
    [Abstract] [Full Text] [Related]

  • 9. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep 08; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D, Moritz ML, Vats A, Janosky JE.
    Am J Hypertens; 2004 Oct 08; 17(10):928-35. PubMed ID: 15485756
    [Abstract] [Full Text] [Related]

  • 11. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
    Wu SC, Liu CP, Chiang HT, Lin SL.
    Heart Vessels; 2004 Jan 08; 19(1):13-8. PubMed ID: 14685749
    [Abstract] [Full Text] [Related]

  • 12. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 08; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 13. Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial.
    Fogari R, Mugellini A, Destro M, Corradi L, Lazzari P, Zoppi A, Preti P, Derosa G.
    Diabet Med; 2012 Jan 08; 29(1):24-31. PubMed ID: 21781149
    [Abstract] [Full Text] [Related]

  • 14. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 08; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 15. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
    Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Donner K, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Kontula K, Hiltunen TP.
    J Hypertens; 2008 Jun 08; 26(6):1250-6. PubMed ID: 18475165
    [Abstract] [Full Text] [Related]

  • 16. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE.
    J Hum Hypertens; 2006 Nov 08; 20(11):860-6. PubMed ID: 16988754
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 08; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of amlodipine and losartan on blood pressure and diurnal variation in hypertensive stroke patients: a prospective, randomized, double-blind, comparative parallel study.
    Kwon HM, Shin JW, Lim JS, Hong YH, Lee YS, Nam H.
    Clin Ther; 2013 Dec 08; 35(12):1975-82. PubMed ID: 24296324
    [Abstract] [Full Text] [Related]

  • 19. Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.
    Praga M, Andrade CF, Luño J, Arias M, Poveda R, Mora J, Prat MV, Rivera F, Galceran JM, Ara JM, Aguirre R, Bernis C, Marín R, Campistol JM.
    Nephrol Dial Transplant; 2003 Sep 08; 18(9):1806-13. PubMed ID: 12937228
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacogenetics of angiotensin system in non diabetic nephropathy].
    Coto E, Marín R, Alvarez V, Praga M, Fernández Andrade C, Arias M, Poveda R, Vallés M, Galcerán JM, Luño J, Rivera F, Campistol JM.
    Nefrologia; 2005 Sep 08; 25(4):381-6. PubMed ID: 16231503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.